Proceedings of the fourth international molecular pathological epidemiology (MPE) meeting.

Epidemiology Humans Neoplasms / epidemiology Pathology, Molecular
Meeting proceedings Meeting report Meeting summary Molecular pathological epidemiology Patho-epidemiology

Journal

Cancer causes & control : CCC
ISSN: 1573-7225
Titre abrégé: Cancer Causes Control
Pays: Netherlands
ID NLM: 9100846

Informations de publication

Date de publication:
Aug 2019
Historique:
received: 28 09 2018
accepted: 27 04 2019
pubmed: 10 5 2019
medline: 18 10 2019
entrez: 10 5 2019
Statut: ppublish

Résumé

An important premise of epidemiology is that individuals with the same disease share similar underlying etiologies and clinical outcomes. In the past few decades, our knowledge of disease pathogenesis has improved, and disease classification systems have evolved to the point where no complex disease processes are considered homogenous. As a result, pathology and epidemiology have been integrated into the single, unified field of molecular pathological epidemiology (MPE). Advancing integrative molecular and population-level health sciences and addressing the unique research challenges specific to the field of MPE necessitates assembling experts in diverse fields, including epidemiology, pathology, biostatistics, computational biology, bioinformatics, genomics, immunology, and nutritional and environmental sciences. Integrating these seemingly divergent fields can lead to a greater understanding of pathogenic processes. The International MPE Meeting Series fosters discussion that addresses the specific research questions and challenges in this emerging field. The purpose of the meeting series is to: discuss novel methods to integrate pathology and epidemiology; discuss studies that provide pathogenic insights into population impact; and educate next-generation scientists. Herein, we share the proceedings of the Fourth International MPE Meeting, held in Boston, MA, USA, on 30 May-1 June, 2018. Major themes of this meeting included 'integrated genetic and molecular pathologic epidemiology', 'immunology-MPE', and 'novel disease phenotyping'. The key priority areas for future research identified by meeting attendees included integration of tumor immunology and cancer disparities into epidemiologic studies, further collaboration between computational and population-level scientists to gain new insight on exposure-disease associations, and future pooling projects of studies with comparable data.

Identifiants

DOI: 10.1007/s10552-019-01177-z PMID: 31069578 PMC: PMC6614001
pubmed: 31069578
doi: 10.1007/s10552-019-01177-z
pii: 10.1007/s10552-019-01177-z
pmc: PMC6614001
mid: NIHMS1029475
doi:

Types de publication

Congress

Langues

eng

Sous-ensembles de citation

IM

Pagination

799-811

Subventions

Organisme : NCI NIH HHS
ID : R35 CA197735
Pays : United States
Organisme : National Institutes of Health (US)
ID : NIH R35 CA197735
Organisme : NCI NIH HHS
ID : R35 CA220523
Pays : United States
Organisme : NCI NIH HHS
ID : U24 CA194354
Pays : United States
Organisme : National Institutes of Health (US)
ID : P30 CA006516
Organisme : National Institutes of Health (US)
ID : 1R01 HL111759
Organisme : NCI NIH HHS
ID : P30 CA006516
Pays : United States
Organisme : National Institutes of Health (US)
ID : 1R35 CA220523
Organisme : NHLBI NIH HHS
ID : R01 HL111759
Pays : United States

Références

Nat Rev Immunol. 2018 Mar;18(3):168-182
pubmed: 29226910
Int J Cancer. 2017 May 15;140(10):2220-2231
pubmed: 28260236
PLoS One. 2013 May 31;8(5):e64832
pubmed: 23741402
Carcinogenesis. 2016 Jun;37(6):531-40
pubmed: 27207657
Nature. 2017 Nov 2;551(7678):92-94
pubmed: 29059683
Cancer Epidemiol Biomarkers Prev. 2008 Dec;17(12):3402-10
pubmed: 19029400
Clin Cancer Res. 2018 Feb 1;24(3):532-534
pubmed: 29097379
Cancer Causes Control. 2014 Mar;25(3):309-19
pubmed: 24343304
Annu Rev Pathol. 2019 Jan 24;14:83-103
pubmed: 30125150
Nat Genet. 2017 Dec;49(12):1767-1778
pubmed: 29058716
Cancer Res. 2017 Nov 1;77(21):e108-e110
pubmed: 29092952
Breast Cancer Res Treat. 2017 Nov;166(2):559-568
pubmed: 28756535
J Mol Diagn. 2016 Sep;18(5):697-706
pubmed: 27471182
JAMA Oncol. 2016 Sep 1;2(9):1197-206
pubmed: 27148825
Cancer Prev Res (Phila). 2016 Sep;9(9):732-8
pubmed: 27590596
Cancer Prev Res (Phila). 2013 Jan;6(1):18-26
pubmed: 23248097
PLoS One. 2009 Nov 23;4(11):e7951
pubmed: 19956740
NPJ Breast Cancer. 2017 Oct 2;3:39
pubmed: 28979927
Gastroenterology. 2017 Dec;153(6):1517-1530.e14
pubmed: 28865736
Nat Commun. 2016 Aug 16;7:12474
pubmed: 27527408
PLoS Comput Biol. 2016 Sep 12;12(9):e1005033
pubmed: 27618581
Nat Genet. 2017 Mar 30;49(4):482-483
pubmed: 28358132
Nature. 2019 Jan;565(7738):234-239
pubmed: 30568305
Nat Commun. 2017 Nov 6;8(1):1324
pubmed: 29109393
J Natl Cancer Inst. 2015 Apr 08;107(5):
pubmed: 25855707
Cell. 2016 Oct 20;167(3):643-656.e17
pubmed: 27768888
J Am Med Inform Assoc. 2020 May 1;27(5):757-769
pubmed: 32364237
AAPS J. 2018 Mar 8;20(2):41
pubmed: 29520676
N Engl J Med. 2015 Jun 25;372(26):2509-20
pubmed: 26028255
Nature. 2017 Jul 13;547(7662):217-221
pubmed: 28678778
J Natl Cancer Inst. 2014 Sep 15;106(10):
pubmed: 25224496
JAMA Oncol. 2016 Aug 1;2(8):1014-22
pubmed: 27055085
Cancer Res. 2018 May 1;78(9):2432-2443
pubmed: 29438991
Breast Cancer Res Treat. 2017 Feb;162(1):139-149
pubmed: 28062981
Cell. 2016 Oct 20;167(3):657-669.e21
pubmed: 27768889
Nat Rev Cancer. 2018 Aug;18(8):500-510
pubmed: 29777175
Cancer Causes Control. 2017 Feb;28(2):167-176
pubmed: 28097472
Mol Cancer Ther. 2017 Jul;16(7):1412-1420
pubmed: 28446639
Cancer Epidemiol Biomarkers Prev. 2014 Sep;23(9):1852-62
pubmed: 24972776
Nucleic Acids Res. 2008 Jan;36(Database issue):D871-7
pubmed: 17989087
Nat Genet. 2019 Mar;51(3):560-567
pubmed: 30742113
Cell Rep. 2017 Oct 24;21(4):1077-1088
pubmed: 29069589
JAMA Oncol. 2016 Oct 01;2(10):1295-1302
pubmed: 27228256
Cancer Discov. 2018 Jun;8(6):730-749
pubmed: 29510987
JAMA Oncol. 2017 Jul 01;3(7):921-927
pubmed: 28125762
Gut. 2009 May;58(5):661-7
pubmed: 18523027
Cancer Epidemiol Biomarkers Prev. 2005 Dec;14(12):2889-97
pubmed: 16365006
J Natl Cancer Inst. 2010 Mar 17;102(6):391-400
pubmed: 20208017
Nat Med. 2018 Oct;24(10):1550-1558
pubmed: 30127393
Dtsch Arztebl Int. 2018 Mar 9;115(10):169-174
pubmed: 29587961
Elife. 2017 Jul 21;6:
pubmed: 28731408
J Pathol. 2017 Feb;241(3):375-391
pubmed: 27861902
Immunity. 2017 Feb 21;46(2):315-326
pubmed: 28228285
Arch Pathol Lab Med. 2014 Sep;138(9):1133-8
pubmed: 25171694
Neuro Oncol. 2018 Nov 12;20(12):1625-1633
pubmed: 30165405
PLoS Genet. 2018 Jun 7;14(6):e1007368
pubmed: 29879116
Carcinogenesis. 2013 Dec;34(12):2757-66
pubmed: 23983135
Cancer Epidemiol Biomarkers Prev. 2016 May;25(5):745-9
pubmed: 26941365
Cancer Epidemiol Biomarkers Prev. 2005 Nov;14(11 Pt 1):2467-71
pubmed: 16284364
Cancer Epidemiol Biomarkers Prev. 2015 Aug;24(8):1229-38
pubmed: 26038390
Proc Natl Acad Sci U S A. 2017 Sep 12;114(37):E7841-E7850
pubmed: 28851834
JAMA Oncol. 2016 Dec 01;2(12):1636-1642
pubmed: 27541161
Gut. 2018 Jun;67(6):1168-1180
pubmed: 29437869
Cell Syst. 2017 Dec 27;5(6):620-627.e3
pubmed: 29153840
J Thorac Dis. 2018 Apr;10(Suppl 7):S876-S881
pubmed: 29780634
Science. 2014 Sep 12;345(6202):1254665
pubmed: 25214635
Lancet. 2018 May 26;391(10135):2084-2086
pubmed: 29754776
J Natl Cancer Inst. 2014 Nov 12;106(11):
pubmed: 25392194
J Thorac Oncol. 2011 Feb;6(2):244-85
pubmed: 21252716
Carcinogenesis. 2015 Sep;36(9):999-1007
pubmed: 26071399
J Natl Cancer Inst. 2013 Dec 18;105(24):1881-90
pubmed: 24292212
Genome Biol. 2016 Aug 22;17(1):174
pubmed: 27549193
Cancer Epidemiol Biomarkers Prev. 2014 Oct;23(10):2027-31
pubmed: 24925673
Gastroenterology. 2016 Nov;151(5):879-892.e4
pubmed: 27475305
Cell Rep. 2016 Apr 26;15(4):857-865
pubmed: 27149842
Breast Cancer Res. 2015 Feb 26;17:29
pubmed: 25849221
Cancer Res. 2018 Oct 1;78(19):5538-5547
pubmed: 30275053
Clin Chem. 2016 Jun;62(6):796-8
pubmed: 27117467
Arch Pathol Lab Med. 2016 Jan;140(1):41-50
pubmed: 26098131
J Natl Cancer Inst. 2011 Feb 2;103(3):250-63
pubmed: 21191117
J Natl Cancer Inst. 2005 Nov 2;97(21):1601-8
pubmed: 16264180
Eur J Epidemiol. 2018 Apr;33(4):381-392
pubmed: 29264788
Science. 2017 Jul 28;357(6349):409-413
pubmed: 28596308
Cancer Causes Control. 2015 Jul;26(7):959-72
pubmed: 25956270
Cancer Epidemiol Biomarkers Prev. 2019 Apr;28(4):798-806
pubmed: 30591591
Tumour Biol. 2018 Feb;40(2):1010428318760342
pubmed: 29484962
Nat Genet. 2016 Jul;48(7):725-32
pubmed: 27240091

Auteurs

Peter T Campbell (PT)

Behavioral and Epidemiology Research Group, American Cancer Society, 250 Williams Street NW, Atlanta, GA, 30303, USA. peter.campbell@cancer.org.

Christine B Ambrosone (CB)

Department of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.

Reiko Nishihara (R)

Program in MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, 450 Brookline Ave, Room SM1036, Boston, MA, 02215, USA.
Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA.

Hugo J W L Aerts (HJWL)

Departments of Radiation Oncology and Radiology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Melissa Bondy (M)

Cancer Prevention and Population Sciences, Dan L. Duncan Comprehensive Cancer Center, Epidemiology and Population Sciences, Department of Medicine, Baylor College of Medicine, Houston, TX, USA.

Nilanjan Chatterjee (N)

Department of Biostatistics, Bloomberg School of Public Health, Department of Oncology, School of Medicine, Johns Hopkins University, Baltimore, MD, USA.

Montserrat Garcia-Closas (M)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

Marios Giannakis (M)

Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
Broad Institute of Harvard & MIT, Cambridge, MA, USA.

Jeffrey A Golden (JA)

Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.

Yujing J Heng (YJ)

Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

N Sertac Kip (NS)

Sema4, Mount Sinai Icahn School of Medicine, Genetics & Genomic Sciences and Pathology, Branford, CT, USA.

Jill Koshiol (J)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

X Shirley Liu (XS)

Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard T.H. Chan School of Public Health, Boston, MA, 02215, USA.

Camila M Lopes-Ramos (CM)

Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA.

Lorelei A Mucci (LA)

Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.

Jonathan A Nowak (JA)

Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.

Amanda I Phipps (AI)

Department of Epidemiology, University of Washington, Seattle, WA, USA.

John Quackenbush (J)

Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA.

Robert E Schoen (RE)

Departments of Medicine and Epidemiology, The University of Pittsburgh, Pittsburgh, PA, USA.

Lynette M Sholl (LM)

Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.

Rulla M Tamimi (RM)

Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.

Molin Wang (M)

Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.

Matty P Weijenberg (MP)

Department of Epidemiology, GROW-School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands.

Catherine J Wu (CJ)

Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
Broad Institute of Harvard & MIT, Cambridge, MA, USA.

Kana Wu (K)

Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, USA.

Song Yao (S)

Department of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.

Kun-Hsing Yu (KH)

Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA.

Xuehong Zhang (X)

Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.

Timothy R Rebbeck (TR)

Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.

Shuji Ogino (S)

Program in MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, 450 Brookline Ave, Room SM1036, Boston, MA, 02215, USA. Shuji_ogino@dfci.harvard.edu.
Broad Institute of Harvard & MIT, Cambridge, MA, USA. Shuji_ogino@dfci.harvard.edu.
Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA. Shuji_ogino@dfci.harvard.edu.
Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA, USA. Shuji_ogino@dfci.harvard.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

Recherchemedicale.com › Professions de santé › Médecine › Épidémiologie › Proceedings of the fourth international...
Recherchemedicale.com › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Proceedings of the fourth international...
Recherchemedicale.com › Tumeurs › Proceedings of the fourth international...
Recherchemedicale.com › Professions de santé › Médecine › Anatomopathologie › Anatomopathologie moléculaire › Proceedings of the fourth international...